Market success of Novo Nordisk’s obesity drug likely to be delayed in Japan, says GlobalData
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Uses a simple mechanical approach for removing intrauterine tissues
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
Good momentum in commercial CDMO business
The net profit in the June quarter was also lower than Rs 146.3 crore reported in the March quarter.
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
The collaboration aims to raise awareness about eye cancer, provide medical and surgical treatment support to children and supply nutritional supplements to aid in their faster recovery.
This acquisition will significantly strengthen Croda’s Beauty Actives portfolio and increases its exposure to targeted prestige segments
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Subscribe To Our Newsletter & Stay Updated